100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Awards
Project Grant HT94252310624
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$725K
Overview
Activity
2
Transactions
2
Subawards
Similar Awards
Federal Agency
Defense Health Agency
Awardee
ST Jude Children's Research Hospital Inc. (JL4JHE9SDRR3)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Update #1
Update #2
XPO1 AS A THERAPEUTIC TARGET IN ZFTA-RELA-DRIVEN EPENDYMOMA
Posted 6/14/23
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
PROJECT TITLE: XPO1 AS A THERAPEUTIC TARGET IN ZFTA-RELA-DRIVEN EPENDYMOMA. THIS MODIFICATION: 1. DE-OBLIGATES $3,082.16, AS A RESULT OF THE COMPLETION OF THE RESEARCH. THE GOVERNMENT HAS CONCLUDED ITS FINANCIAL OBLIGATION. THE TOTAL AWARD AMOUNT HAS BEEN REDUCED FROM $728,000.00 TO $724,917.84. THE FINAL TECHNICAL REPORT HAS NOT BEEN SUBMITTED. IF THE FINAL TECHNICAL REPORT IS DETERMINED TO BE UNACCEPTABLE/ DISAPPROVED, THE RECIPIENT IS REQUIRED TO ENSURE THAT THE REPORT IS RESUBMITTED AND ULTIMATELY APPROVED TO MEET THE OBLIGATIONS UNDER THIS AWARD. 2. UPDATES DIVISION I ITEM A.4, A.5II, AND A.6.
($3k)
3/20/26
Not listed
XPO1 AS A THERAPEUTIC TARGET IN ZFTA-RELA-DRIVEN EPENDYMOMA
$728.0k
6/14/23